Literature DB >> 4076066

Electrographic and clinical correlates of secondary bilateral synchrony.

W T Blume, N Pillay.   

Abstract

Reverting to the more strict definition of secondary bilateral synchrony (SBS) of Tukel and Jasper (1952), we reexamined clinical and EEG correlates of this phenomenon. SBS occurred in 57 of 10,410 consecutive patients (0.5%) recorded in our laboratory. SBS originated in the frontal lobe in 51% of patients, significantly more often than the incidence of frontal spikes among controls. The best indicator of SBS origin was the most active spike focus which localized the onset in 52 of the 57 patients (91%) and falsely identified the origin in only one. Other focal or lateralizing clinical and EEG features appeared each in a minority of patients and lateralized and/or localized SBS origin with the following incidences when present: seizure manifestations (86%), neurological examination (95%), focal delta (100%), focal or unilateral theta (100%), and offset of bisynchronous paroxysms (96%). However, the most active spike focus triggered SBS in all but two instances when these other features appeared. Reliability of such indicators of SBS origin may obviate the need for depth electroencephalography in such patients. The presence of more than one spike focus in 96% of patients and three or more foci in 77% suggests that SBS results from a complex interaction of multiple potentially epileptogenic regions, instead of spread from a single focus as previously thought.

Entities:  

Mesh:

Year:  1985        PMID: 4076066     DOI: 10.1111/j.1528-1157.1985.tb05704.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

1.  Focal and generalized: both here and there.

Authors:  Warren T Blume
Journal:  Epilepsy Curr       Date:  2010-09       Impact factor: 7.500

2.  Vagus nerve stimulation: predictors of seizure freedom.

Authors:  J Janszky; M Hoppe; F Behne; I Tuxhorn; H W Pannek; A Ebner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

3.  Investigation of bilateral synchronous spike-wave discharge by EEG topography.

Authors:  H Yoshinaga; K Kobayashi; M Sato; E Oka; S Ohtahara
Journal:  Brain Topogr       Date:  1996       Impact factor: 3.020

Review 4.  Magnetoencephalography: clinical application in epilepsy.

Authors:  Robert C Knowlton
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

5.  Magnetic source imaging for the surgical evaluation of electroencephalography-confirmed secondary bilateral synchrony in intractable epilepsy.

Authors:  Edward F Chang; Srikantan S Nagarajan; Mary Mantle; Nicholas M Barbaro; Heidi E Kirsch
Journal:  J Neurosurg       Date:  2009-12       Impact factor: 5.115

6.  Coexistence of symptomatic focal and absence seizures: video-EEG and EEG-fMRI evidence of overlapping but independent epileptogenic networks.

Authors:  Serge Chassagnon; Colin S Hawko; Andrea Bernasconi; Jean Gotman; François Dubeau
Journal:  Epilepsia       Date:  2009-04-27       Impact factor: 5.864

7.  Secondary bilateral synchrony in unilateral pial angiomatosis: successful surgical treatment.

Authors:  J J Chevrie; N Specola; J Aicardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

8.  Burst suppression uncovers rapid widespread alterations in network excitability caused by an acute seizure focus.

Authors:  Jyun-You Liou; Eliza Baird-Daniel; Mingrui Zhao; Andy Daniel; Catherine A Schevon; Hongtao Ma; Theodore H Schwartz
Journal:  Brain       Date:  2019-10-01       Impact factor: 13.501

9.  Focal Epileptogenic Lesions in Adult Patients with Epilepsy and Generalized Epileptiform Discharges.

Authors:  Dong Wook Kim; Seo-Young Lee; Sang Kun Lee
Journal:  J Epilepsy Res       Date:  2016-12-31

Review 10.  Electroencephalography in the Diagnosis of Genetic Generalized Epilepsy Syndromes.

Authors:  Udaya Seneviratne; Mark J Cook; Wendyl Jude D'Souza
Journal:  Front Neurol       Date:  2017-09-25       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.